These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
815 related articles for article (PubMed ID: 27081744)
1. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery. Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744 [TBL] [Abstract][Full Text] [Related]
2. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510 [TBL] [Abstract][Full Text] [Related]
3. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985 [TBL] [Abstract][Full Text] [Related]
4. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199 [TBL] [Abstract][Full Text] [Related]
5. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Koeth RA; Levison BS; Culley MK; Buffa JA; Wang Z; Gregory JC; Org E; Wu Y; Li L; Smith JD; Tang WHW; DiDonato JA; Lusis AJ; Hazen SL Cell Metab; 2014 Nov; 20(5):799-812. PubMed ID: 25440057 [TBL] [Abstract][Full Text] [Related]
6. The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection. Trøseid M; Mayerhofer CCK; Broch K; Arora S; Svardal A; Hov JR; Andreassen AK; Gude E; Karason K; Dellgren G; Berge RK; Gullestad L; Aukrust P; Ueland T J Heart Lung Transplant; 2019 Oct; 38(10):1097-1103. PubMed ID: 31301965 [TBL] [Abstract][Full Text] [Related]
7. The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism. Buffa JA; Romano KA; Copeland MF; Cody DB; Zhu W; Galvez R; Fu X; Ward K; Ferrell M; Dai HJ; Skye S; Hu P; Li L; Parlov M; McMillan A; Wei X; Nemet I; Koeth RA; Li XS; Wang Z; Sangwan N; Hajjar AM; Dwidar M; Weeks TL; Bergeron N; Krauss RM; Tang WHW; Rey FE; DiDonato JA; Gogonea V; Gerberick GF; Garcia-Garcia JC; Hazen SL Nat Microbiol; 2022 Jan; 7(1):73-86. PubMed ID: 34949826 [TBL] [Abstract][Full Text] [Related]
8. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824 [TBL] [Abstract][Full Text] [Related]
9. Ruminant meat and milk contain δ-valerobetaine, another precursor of trimethylamine N-oxide (TMAO) like γ-butyrobetaine. Servillo L; D'Onofrio N; Giovane A; Casale R; Cautela D; Castaldo D; Iannaccone F; Neglia G; Campanile G; Balestrieri ML Food Chem; 2018 Sep; 260():193-199. PubMed ID: 29699662 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336 [TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL Nat Med; 2013 May; 19(5):576-85. PubMed ID: 23563705 [TBL] [Abstract][Full Text] [Related]
12. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Wang Z; Bergeron N; Levison BS; Li XS; Chiu S; Jia X; Koeth RA; Li L; Wu Y; Tang WHW; Krauss RM; Hazen SL Eur Heart J; 2019 Feb; 40(7):583-594. PubMed ID: 30535398 [TBL] [Abstract][Full Text] [Related]
13. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial. Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027 [TBL] [Abstract][Full Text] [Related]
14. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice. Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979 [TBL] [Abstract][Full Text] [Related]
15. Association of gut-related metabolites with outcome in acute heart failure. Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370 [TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448 [TBL] [Abstract][Full Text] [Related]
17. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome. Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132 [TBL] [Abstract][Full Text] [Related]
18. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection. Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263 [TBL] [Abstract][Full Text] [Related]
19. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota. Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200 [TBL] [Abstract][Full Text] [Related]
20. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. Romano KA; Vivas EI; Amador-Noguez D; Rey FE mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]